Cresset Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
14,807
+271
| +2% | +$28.8K | 0.01% | 625 |
|
|
2025
Q1 | $1.8M | Sell |
14,536
-2,307
| -14% | -$286K | 0.01% | 562 |
|
|
2024
Q4 | $2.07M | Sell |
16,843
-16,606
| -50% | -$2.05M | 0.01% | 528 |
|
|
2024
Q3 | $3.73M | Buy |
33,449
+14,905
| +80% | +$1.66M | 0.01% | 523 |
|
|
2024
Q2 | $1.98M | Buy |
18,544
+1,893
| +11% | +$202K | 0.01% | 704 |
|
|
2024
Q1 | $2.01M | Buy |
16,651
+14,266
| +598% | +$1.72M | 0.01% | 628 |
|
|
2023
Q4 | $293K | Sell |
2,385
-1,446
| -38% | -$178K | ﹤0.01% | 1475 |
|
|
2023
Q3 | $496K | Buy |
3,831
+1,111
| +41% | +$144K | ﹤0.01% | 1151 |
|
|
2023
Q2 | $337K | Buy |
+2,720
| New | +$337K | ﹤0.01% | 1338 |
|
|
2019
Q2 | – | Sell |
-485
| Closed | -$69K | – | 1071 |
|
|
2019
Q1 | $69K | Buy |
485
+262
| +117% | +$37.3K | ﹤0.01% | 674 |
|
|
2018
Q4 | $28K | Buy |
+223
| New | +$28K | ﹤0.01% | 643 |
|